Suppr超能文献

快速诊断与抗菌药物管理的整合可改善抗生素耐药革兰氏阴性菌血症患者的结局。

Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.

机构信息

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Pharmacy, Houston Methodist Hospital, Houston, TX 77030, USA.

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA.

出版信息

J Infect. 2014 Sep;69(3):216-25. doi: 10.1016/j.jinf.2014.05.005. Epub 2014 May 17.

Abstract

BACKGROUND

An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly improved patient outcomes and reduced hospital costs. As antibiotic resistance rates continue to grow at an alarming speed, the current study was undertaken to assess the impact of this intervention in a challenging patient population with bloodstream infections caused by antibiotic-resistant Gram-negative bacteria.

METHODS

A total of 153 patients with antibiotic-resistant Gram-negative bacteremia hospitalized prior to the study intervention were compared to 112 patients treated post-implementation. Outcomes assessed included time to optimal antibiotic therapy, time to active treatment when inactive, hospital and intensive care unit length of stay, all-cause 30-day mortality, and total hospital expenditures.

RESULTS

Integrating rapid diagnostics with antimicrobial stewardship improved time to optimal antibiotic therapy (80.9 h in the pre-intervention period versus 23.2 h in the intervention period, P < 0.001) and effective antibiotic therapy (89.7 h versus 32 h, P < 0.001). Patients in the pre-intervention period had increased duration of hospitalization compared to those in the intervention period (23.3 days versus 15.3 days, P = 0.0001) and longer intensive care unit length of stay (16 days versus 10.7 days, P = 0.008). Mortality among patients during the intervention period was lower (21% versus 8.9%, P = 0.01) and our study intervention remained a significant predictor of survival (OR, 0.3; 95% confidence interval [CI], 0.12-0.79) after multivariate logistic regression. Mean hospital costs for each inpatient survivor were reduced $26,298 in the intervention cohort resulting in an estimated annual cost savings of $2.4 million (P = 0.002).

CONCLUSIONS

Integration of rapid identification and susceptibility techniques with antimicrobial stewardship resulted in significant improvements in clinical and financial outcomes for patients with bloodstream infections caused by antibiotic-resistant Gram-negatives. The intervention decreased hospital and intensive care unit length of stay, total hospital costs, and reduced all-cause 30-day mortality.

摘要

背景

一项将快速诊断质谱技术与抗菌药物管理相结合的革兰氏阴性菌血流感染干预措施显著改善了患者的预后并降低了医院的成本。由于抗生素耐药率以惊人的速度持续增长,本研究旨在评估该干预措施在具有由抗生素耐药革兰氏阴性菌引起的血流感染的挑战性患者人群中的影响。

方法

研究比较了在研究干预前住院的 153 名抗生素耐药革兰氏阴性菌菌血症患者与 112 名接受干预后的患者。评估的结果包括最佳抗生素治疗的时间、无活性治疗的活跃治疗时间、住院和重症监护病房的住院时间、全因 30 天死亡率和总医院支出。

结果

快速诊断与抗菌药物管理相结合,改善了最佳抗生素治疗的时间(干预前为 80.9 小时,干预期间为 23.2 小时,P<0.001)和有效抗生素治疗的时间(89.7 小时对 32 小时,P<0.001)。与干预组相比,干预前组的住院时间延长(23.3 天对 15.3 天,P=0.0001),重症监护病房的住院时间延长(16 天对 10.7 天,P=0.008)。干预期间患者的死亡率较低(21%对 8.9%,P=0.01),并且我们的研究干预措施仍然是多变量逻辑回归后生存的显著预测因素(OR,0.3;95%置信区间[CI],0.12-0.79)。在干预组中,每位住院幸存者的平均医院费用降低了 26298 美元,估计每年节省成本 240 万美元(P=0.002)。

结论

快速鉴定和药敏技术与抗菌药物管理相结合,显著改善了抗生素耐药革兰氏阴性菌引起的血流感染患者的临床和经济结果。该干预措施缩短了住院和重症监护病房的住院时间、总医院费用,并降低了全因 30 天死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验